On March 15, 2024, Davidson Kempner Capital Management LP announced that it has and continue to engage in discussions with Invacare Corporation?s management, Board and other stockholders with respect to the matters previously set forth in the Schedule 13D and may in the future take actions with respect to their investment in the Company with respect thereto. Davidson Kempner Capital has had discussions with the stockholders, and together with the stockholders, are in discussions with the Company?s management and the Board to explore further financing proposals, which contemplate the issuance of additional securities of the Company or its subsidiaries to Davidson Kempner Capital and the stockholders. In connection therewith, the Company and the lenders under the Loan and Security Agreement, as amended, entered into a term sheet with non-binding terms for a potential further financing and, in consideration with incurring costs and expenses with respect to such discussions, a termination fee payable to the lenders in the event the Company pursues alternative financing prior to April 30, 2024.

There can be no guarantee that any of Davidson Kempner Capital will enter into any such transaction, either on its own or in conjunction with some or all of the named stockholders.